Trevor Scheid

Trevor Scheid has an extensive work experience spanning multiple companies and roles. Trevor began their career as a Summer Intern at Deutsche Bank in 2011. Trevor then moved on to work at IMS Consulting Group as a Modeler Analyst from July 2012 to January 2014, before being promoted to an Associate Consultant until June 2015. Trevor then joined Genentech where they held various positions, including Associate Forecast Manager from June 2015 to February 2016, Forecast Manager from February 2016 to August 2017, and ultimately Senior Manager of Market Analysis and Strategy from September 2017 to March 2019. Following that, they worked at Global Blood Therapeutics as a Senior Manager of Forecasting and National Analytics from April 2019 to September 2020, and then as an Associate Director of Commercial Insights from September 2020 to March 2021. Currently, Trevor is employed at TG Therapeutics, Inc. as the Director of MS Strategic Planning, Analytics, and Insights since March 2021, and was recently promoted to Senior Director in March 2022.

Trevor Scheid obtained a Bachelor of Science degree in Management Science and Engineering from Stanford University, where they studied from 2008 to 2012. In addition to their formal education, Trevor has also obtained several certifications, including "Predictive Customer Analytics" and "Python: Working with Predictive Analytics" from LinkedIn in September 2019. Trevor also completed a certification titled "The Data Science of Healthcare, Medicine, and Public Health, with Barton Poulson" from LinkedIn in September 2019.